Evidence map›Paper›PMID 33672064›Full record

ReviewInternational journal of environmental research and public health2021

Implementing Precision Medicine in Human Frailty through Epigenetic Biomarkers.

José Luis García-Giménez, Salvador Mena-Molla, Francisco José Tarazona-Santabalbina, Jose Viña, Mari Carmen Gomez-Cabrera, Federico V Pallardó

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06975540 (Study of the Synergy Between Physical Exercise and a Nutritional Supplement for the Prevention and Treatment of Frailty), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06975540 nacompletednot on this map

Study of the Synergy Between Physical Exercise and a Nutritional Supplement for the Prevention and Treatment of Frailty: The ROBUSTNES Study

TypeinterventionalSponsorFundación para la Investigación del Hospital Clínico de ValenciaRan2019 to 2022Enrolled47ConditionsFrail ElderlyArmsMultidomain physical exercise
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

José Luis García-GiménezU733, Centre for Biomedical Network Research on Rare Diseases (CIBERER-ISCIII), 28029 Madrid, Spain.ORCID 0000-0001-7547-7872
Salvador Mena-MollaDepartment of Physiology, Faculty of Medicine, University of Valencia, 46003 Valencia, Spain.
Francisco José Tarazona-SantabalbinaServicio de Geriatría, Hospital Universitario de la Ribera, CIBERFES, Alzira, 46010 Valencia, Spain.ORCID 0000-0003-4531-1446
Jose ViñaFreshage Research Group, Department of Physiology, Faculty of Medicine, Institute of Health Research-INCLIVA, University of Valencia and CIBERFES, 46010 Valencia, Spain.ORCID 0000-0001-9709-0089
Mari Carmen Gomez-CabreraFreshage Research Group, Department of Physiology, Faculty of Medicine, Institute of Health Research-INCLIVA, University of Valencia and CIBERFES, 46010 Valencia, Spain.ORCID 0000-0003-4000-1684
Federico V PallardóU733, Centre for Biomedical Network Research on Rare Diseases (CIBERER-ISCIII), 28029 Madrid, Spain.ORCID 0000-0003-3715-1980
Universitat de València · ESHospital de La Ribera · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main epigenetic features in aging are: reduced bulk levels of core histones, altered pattern of histone post-translational modifications, changes in the pattern of DNA methylation, replacement of canonical histones with histone variants, and altered expression of non-coding RNA. The identification of epigenetic mechanisms may contribute to the early detection of age-associated subclinical changes or deficits at the molecular and/or cellular level, to predict the development of frailty, or even more interestingly, to improve health trajectories in older adults. Frailty reflects a state of increased vulnerability to stressors as a result of decreased physiologic reserves, and even dysregulation of multiple physiologic systems leading to adverse health outcomes for individuals of the same chronological age. A key approach to overcome the challenges of frailty is the development of biomarkers to improve early diagnostic accuracy and to predict trajectories in older individuals. The identification of epigenetic biomarkers of frailty could provide important support for the clinical diagnosis of frailty, or more specifically, to the evaluation of its associated risks. Interventional studies aimed at delaying the onset of frailty and the functional alterations associated with it, would also undoubtedly benefit from the identification of frailty biomarkers. Specific to the article yet reasonably common within the subject discipline.

Indexed as

FrailtyAgedAgingBiomarkersEpigenesis, GeneticFrail ElderlyHumansPrecision MedicineBiomarkersDNA methylationexercisegeriatric syndromeshealthy aginghistonesnon-coding RNA

Identifiers

PMID33672064
PMCPMC7919465
OpenAlexW3130384748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.